Zevra Therapeutics Inc (ZVRA)
9.585
+0.46
(+4.98%)
USD |
NASDAQ |
Nov 22, 16:00
9.64
+0.06
(+0.57%)
After-Hours: 20:00
Zevra Therapeutics Cash from Investing (Quarterly): -31.35M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -31.35M |
| June 30, 2024 | -0.129M |
| March 31, 2024 | 14.79M |
| December 31, 2023 | 10.58M |
| September 30, 2023 | -44.46M |
| June 30, 2023 | 34.04M |
| March 31, 2023 | -17.56M |
| December 31, 2022 | -0.063M |
| September 30, 2022 | 0.272M |
| June 30, 2022 | -33.08M |
| March 31, 2022 | -3.848M |
| December 31, 2021 | -15.44M |
| September 30, 2021 | -0.004M |
| June 30, 2021 | -0.081M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.026M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.004M |
| March 31, 2020 | -0.011M |
| December 31, 2019 | -0.005M |
| September 30, 2019 | -0.004M |
| June 30, 2019 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2019 | 3.243M |
| December 31, 2018 | 7.964M |
| September 30, 2018 | 0.457M |
| June 30, 2018 | 15.68M |
| March 31, 2018 | 9.229M |
| December 31, 2017 | 10.02M |
| September 30, 2017 | 5.655M |
| June 30, 2017 | 6.039M |
| March 31, 2017 | 5.702M |
| December 31, 2016 | 5.739M |
| September 30, 2016 | 3.615M |
| June 30, 2016 | -40.47M |
| March 31, 2016 | -14.73M |
| December 31, 2015 | -19.04M |
| September 30, 2015 | -0.055M |
| June 30, 2015 | -0.019M |
| March 31, 2015 | -0.021M |
| December 31, 2014 | -0.03M |
| September 30, 2014 | -0.006M |
| June 30, 2014 | -0.007M |
| March 31, 2014 | -0.004M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-44.46M
Minimum
Sep 2023
34.04M
Maximum
Jun 2023
-4.318M
Average
-0.0185M
Median
Cash from Investing (Quarterly) Benchmarks
| Johnson & Johnson | -3.128B |
| Ionis Pharmaceuticals Inc | -340.80M |
| Vanda Pharmaceuticals Inc | 12.06M |
| BioCardia Inc | -0.002M |
| Xeris Biopharma Holdings Inc | 9.914M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -18.14M |
| Cash from Financing (Quarterly) | 64.76M |
| Free Cash Flow | -69.57M |
| Free Cash Flow Per Share (Quarterly) | -0.3794 |
| Free Cash Flow to Equity (Quarterly) | -18.72M |
| Free Cash Flow to Firm (Quarterly) | -16.88M |
| Free Cash Flow Yield | -17.06% |